Prognostic and therapeutic implications of disulfidptosis-related genes in multiple myeloma
We established and validated a novel disulfidptosis-related prognostic model for MM, providing a potential biomarker for risk stratification and guidance for personalized therapeutic decisions.
Authors
- Haotian Dong (ORCID: https://orcid.org/0000-0002-4438-9332)
- Jingfei Wang (ORCID: https://orcid.org/0000-0003-1035-1069)
- Yanhua Sun (ORCID: https://orcid.org/0000-0003-0877-9859)
- Guimao Yang
- Yanli Sun (ORCID: https://orcid.org/0000-0002-8883-5226)
- Peipei Zhou (ORCID: https://orcid.org/0009-0009-3589-5020)
- Qianqian Wu (ORCID: https://orcid.org/0000-0003-4820-5235)
- Yun Zang
- Rongxuan Cao
Institutions
- Weifang Medical University (CN)
- Weifang People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.3389/fimmu.2025.1652179
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00